IP Verse

Recombinant Gallid Herpesvirus 3 (Mdv Serotype 2) Vectors Expressing Antigens Of Avian Pathogens And Uses Thereof - EP2785374

PATENT ANALYSIS

Patent Details

Grant Date
Aug 17, 2022
Company
BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.
Oppositions

INTERVET INTERNATIONAL B.V.

More patents of Boehringer Ingelheim Animal Health Usa Inc.

EP3035958

EP3554536

EP2785374

Want to monitor this patent?

Feel free to send us a message here and we will get back to you